A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors
NCT07534813
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
BIOLOGICAL:
GT307 injection
Sponsor
Grit Biotechnology
Collaborators
Fudan University